| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.SEMCANCER.2010.04.002 |
| P698 | PubMed publication ID | 20435143 |
| P2093 | author name string | Mark Shackleton | |
| P433 | issue | 2 | |
| P921 | main subject | neoplastic stem cells | Q1638475 |
| P304 | page(s) | 85-92 | |
| P577 | publication date | 2010-04-29 | |
| P1433 | published in | Seminars in Cancer Biology | Q1908668 |
| P1476 | title | Normal stem cells and cancer stem cells: similar and different | |
| P478 | volume | 20 |
| Q26744651 | A New Biological Feature of Natural Killer Cells: The Recognition of Solid Tumor-Derived Cancer Stem Cells |
| Q42269157 | A comprehensive promoter landscape identifies a novel promoter for CD133 in restricted tissues, cancers, and stem cells. |
| Q34236699 | A model of cancer stem cells derived from mouse induced pluripotent stem cells |
| Q36161952 | Alteration of colonic stem cell gene signatures during the regenerative response to injury |
| Q39214227 | Anti-Cancer Phytometabolites Targeting Cancer Stem Cells |
| Q38971795 | Approaches for targeting cancer stem cells drug resistance |
| Q90604494 | Broad and thematic remodeling of the surfaceome and glycoproteome on isogenic cells transformed with driving proliferative oncogenes |
| Q95654910 | CD133 inhibition via autophagic degradation in pemetrexed-resistant lung cancer cells by GMI, a fungal immunomodulatory protein from Ganoderma microsporum |
| Q98165028 | CITED2 and the modulation of the hypoxic response in cancer |
| Q91907215 | Cancer Stem Cells: From Historical Roots to a New Perspective |
| Q38707592 | Cancer Stem Cells: Plasticity Works against Therapy |
| Q37885165 | Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations |
| Q37039289 | Cancer stem cell hypothesis: a brief summary and two proposals |
| Q60934336 | Cancer stem cell impact on clinical oncology |
| Q37841186 | Cancer stem cells and cancer therapy |
| Q38007261 | Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links |
| Q38702970 | Cancer stem cells and personalized cancer nanomedicine. |
| Q37288044 | Cancer stem cells as a potential therapeutic target in thyroid carcinoma |
| Q37896083 | Cancer stem cells in osteosarcoma: recent progress and perspective |
| Q43138601 | Cancer stem cells in surgery |
| Q38842832 | Comparative gene-expression profiling of CD133(+) and CD133(-) D10 melanoma cells |
| Q37874575 | Continued growth and circuit building in the anamniote visual system. |
| Q58483427 | Cytokine Networks and Cancer Stem Cells |
| Q39592837 | Differentiation-inducing activity of hydroxycamptothecin on cancer stem-like cells derived from hepatocellular carcinoma |
| Q64252970 | Dual Oncogenic/Anti-Oncogenic Role of PATZ1 in FRTL5 Rat Thyroid Cells Transformed by the Oncogene |
| Q88738683 | Expression of cancer stem cell markers CD44, ALDH1 and p75NTR in actinic cheilitis and lip cancer |
| Q35156404 | Getting to the source: selective drug targeting of cancer stem cells |
| Q92756045 | Hedgehog Pathway as a Potential Intervention Target in Esophageal Cancer |
| Q37821337 | Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect |
| Q39483028 | Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties |
| Q57112976 | Mammary Stem Cells and Breast Cancer Stem Cells: Molecular Connections and Clinical Implications |
| Q38828353 | Mechanisms of tumor cell resistance to the current targeted-therapy agents. |
| Q35093171 | MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell |
| Q42726342 | MicroRNA-124 Targets Tip110 Expression and Regulates Hematopoiesis. |
| Q55379662 | MicroRNA-30b targets Snail to impede epithelial-mesenchymal transition in pancreatic cancer stem cells. |
| Q36001860 | Molecular marks for epigenetic identification of developmental and cancer stem cells |
| Q26780164 | Molecular mechanisms controlling asymmetric and symmetric self-renewal of cancer stem cells |
| Q58277244 | Multidrug Efflux Pumps and Cancer Stem Cells: Insights Into Multidrug Resistance and Therapeutic Development |
| Q28078448 | NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer? |
| Q60584710 | Nitric oxide promotes cancer cell dedifferentiation by disrupting an Oct4:caveolin-1 complex: A new regulatory mechanism for cancer stem cell formation |
| Q41771086 | Overcoming Multidrug Resistance in Cancer Stem Cells |
| Q47229479 | Peptide-targeted, stimuli-responsive polymersomes for delivering a cancer stemness inhibitor to cancer stem cell microtumors |
| Q36108404 | Preparation of epithelial and mesenchymal stem cells from murine mammary gland |
| Q34552547 | Progress in understanding melanoma propagation |
| Q64061376 | Recent Advances in Cancer Stem Cell-Targeted Immunotherapy |
| Q92874495 | Role of the Microenvironment in Regulating Normal and Cancer Stem Cell Activity: Implications for Breast Cancer Progression and Therapy Response |
| Q90727444 | Starvation and Pseudo-Starvation as Drivers of Cancer Metastasis through Translation Reprogramming |
| Q26765858 | Stem Cell Modeling of Core Binding Factor Acute Myeloid Leukemia |
| Q37985376 | Stem cells in brain tumour development and therapy- two-sides of the same coin. |
| Q28390451 | The circadian clock in cancer development and therapy |
| Q37940376 | The proteomics of cancer stem cells: potential clinical applications for innovative research in oncology |
| Q37946457 | The three M's: melanoma, microphthalmia-associated transcription factor and microRNA. |
| Q100530748 | Transitional dynamics of cancer stem cells in invasion and metastasis |
| Q38476083 | Translational potential of cancer stem cells: A review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment |
| Q41699685 | Withanolide D Exhibits Similar Cytostatic Effect in Drug-Resistant and Drug-Sensitive Multiple Myeloma Cells. |
Search more.